Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study

Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study

Background: Patients treated for intermediate- or high-risk differentiated thyroid carcinoma (DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body scan (DWBS) and if positive, 131I treatment. This approach can lead to a delay in treatment and increased costs. The p...

Full description

Bibliographic Details
Main Authors: José F. Carrillo, Rafael Vázquez-Romo, Margarita C. Ramírez-Ortega, Liliana C. Carrillo, Edgar Gómez-Argumosa, Luis F. Oñate-Ocaña
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Endocrinology
Subjects:
differentiated thyroid cancer
131I treatment
thyroglobulin
diagnostic whole body scan
cohort studies
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00737/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00737/full

Similar Items